Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Dr. Rodolfo Pinto Almazán, Escuela Superior de Medicina, IPN, Mexico

Dr. Rodolfo Pinto Almazán is a prominent researcher and professor specializing in biomedical sciences and pharmacology. Currently a Level II member of the National System of Researchers (SNI) and a professor at the Instituto Politécnico Nacional (IPN), Mexico, he has made significant contributions to metabolic and neurodegenerative disease research. With a postdoctoral fellowship at USC and Children’s Hospital Los Angeles, Dr. Pinto has authored groundbreaking studies on oxidative stress and brain function. His honors include the Best Research Manuscript Award (2023) and multiple accolades for his impactful research. 📚🔬👨‍🔬🎓

Publication Profile

Scopus

Research Experience and Achievements

Dr. Rodolfo Pinto Almazán is a distinguished researcher with extensive experience in biomedical sciences. He has been a member of the National System of Researchers (SNI) since 2016, currently at Level II. Dr. Pinto is a professor at the Instituto Politécnico Nacional (IPN) and has worked in various prestigious roles, including postdoctoral research at the University of Southern California (USC) and Children’s Hospital Los Angeles. He has contributed significantly to the study of metabolic and neurodegenerative diseases. His career includes multiple research fellowships and awards. 📚🔬🎓👨‍🔬

Educational Background

Dr. Rodolfo Pinto Almazán holds a distinguished academic background in biomedical sciences. He completed his postdoctoral fellowship at the Keck School of Medicine, USC, and Children’s Hospital Los Angeles (2016–2017), studying sex differences in the central nervous system due to early-life stress. He earned his Ph.D. in Biomedical Sciences from the National Autonomous University of Mexico (UNAM) in 2014, focusing on oxidative stress in the hippocampus. Dr. Pinto also holds a Master’s degree in Pharmacology from the Instituto Politécnico Nacional (IPN), where he studied tau protein activation. His Bachelor’s degree in Pharmaceutical Chemistry was awarded by La Salle University, Mexico. 🎓🔬📚👨‍🔬

Technical Experience

Dr. Rodolfo Pinto Almazán possesses extensive technical expertise in histological and molecular techniques. He is skilled in cryosectioning, immunohistochemistry, and cellular staining. His molecular techniques include DNA/RNA extraction, PCR, ELISA, and Western Blot. Dr. Pinto is proficient with laboratory equipment such as HPLC, NanoDrop, cryostats, thermal cyclers, histoquinescence, and both confocal and optical microscopes. He has hands-on experience with animal handling, including injections, surgeries, ovariectomies, and behavioral tests like the Plus Maze and Morris Water Maze. He also excels in laboratory management, overseeing training, budgeting, and protocol optimization. 🧪🔬🧑‍🔬🐁💻

Teaching Experience

Dr. Rodolfo Pinto Almazán has extensive teaching experience across various levels. He served as an invited professor for the “Molecular Bases of Neurological Diseases” course in the Doctoral program in Biomedical Sciences at UNAM in 2017. He has also taught multiple courses in the Master’s program in Health Sciences at the Escuela Superior de Medicina (ESM, IPN) including Clinical Research, Bioethics, and Biostatistics. In addition, Dr. Pinto has taught Medical Residency courses in Pharmacology, Biochemistry, and Research Methodology at institutions like HRAEI, UAEH, and IMSS. His undergraduate teaching spans subjects like Biochemistry, Cellular Biology, and Pharmacology at UVM, demonstrating his wide-ranging expertise in medical and health sciences education. 📚🧑‍🏫💉

Research Focus

Dr. Rodolfo Pinto Almazán’s research focuses primarily on medical mycology, neuroprotection, and metabolic health. His work explores the neuroprotective effects of sex steroids in spinal cord injury, the virulence factors of fungi like Microsporum canis and Nakaseomyces glabratus, and their association with various skin diseases. Additionally, his research includes investigating metabolic disorders, inflammation, and the effects of omega-3 fatty acids in COVID-19 patients. His contributions span topics such as trauma, fungal infections, and neurodegenerative conditions, emphasizing the importance of therapeutic interventions. 🔬🧠🦠🧑‍🔬

Publication Top Notes 

  • Effect of Chronic Tibolone Administration on Memory and Choline Acetyltransferase and Tryptophan Hydroxylase Content in Aging Mice – Castillo-Mendieta, T., Bautista-Poblet, G., Coyoy-Salgado, A., Neri-Gómez, T., Guerra-Araiza, C. (2024) 🧠📚 – 0 citations
  • Mortality-Associated Factors in a Traumatic Brain Injury Population in Mexico – Martínez-Herrera, E., Galindo-Oseguera, E., Castillo-Cruz, J., Arellano-Ramírez, A., Pinto-Almazán, R. (2024) ⚠️💀 – 0 citations
  • Evaluating Sex Steroid Hormone Neuroprotection in Spinal Cord Injury in Animal Models: Is It Promising in the Clinic? – Coyoy-Salgado, A., Segura-Uribe, J., Salgado-Ceballos, H., Moralí de la Brena, G., Guerra-Araiza, C. (2024) 🧠💉 – 0 citations
  • Cutaneous Fusarium Disease and Leukaemias: A Systematic Review – Cortés-López, P.N., Guzmán-Montijo, E., Fuentes-Venado, C.E., Pinto-Almazán, R., Martínez-Herrera, E. (2024) 🦠🩺 – 0 citations
  • Fungal Melanonychia: A Systematic Review – Rodríguez-Cerdeira, C., Martínez-Herrera, E., Cortés-López, P.N., Vega-Sánchez, D.C., Pinto-Almazán, R. (2024) 🦠💅 – 2 citations
  • Remarkable Phenotypic Virulence Factors of Microsporum canis and Their Associated Genes: A Systematic Review – Vite-Garín, T., Estrada-Cruz, N.A., Hernández-Castro, R., Martínez-Herrera, E., Pinto-Almazán, R. (2024) 🦠💪 – 4 citations
  • Virulence and Resistance Factors of Nakaseomyces glabratus (formerly known as Candida glabrata) in Europe: A Systematic Review – Rodríguez-Cerdeira, C., Pinto-Almazán, R., Saunte, D.M.L., Prohic, A., Martínez-Herrera, E. (2024) 🦠🔬 – 1 citation
  • Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19 – Rodríguez-Vera, D., Salazar, J.R., Soriano-Ursúa, M.A., Loza-Mejía, M.A., Pinto-Almazán, R. (2024) 🐟💪 – 1 citation
  • In Silico and In Vivo Evaluation of the Maqui Berry (Aristotelia chilensis (Mol.) Stuntz) on Biochemical Parameters and Oxidative Stress Markers in a Metabolic Syndrome Model – Castillo-García, E.L., Cossio-Ramírez, A.L., Córdoba-Méndez, Ó.A., Gallardo, J.M., Guerra-Araiza, C. (2023) 🍇⚖️ – 0 citations
  • Main Phenotypic Virulence Factors Identified in Trichophyton Rubrum – Martínez-Herrera, E., Moreno-Coutiño, G., Fuentes-Venado, C.E., Pinto-Almazán, R., Rodríguez-Cerdeira, C. (2023) 🦠🦶 – 3 citations

Hua Jin | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Hua Jin | Pharmacology | Women Researcher Award

Assoc Prof Dr. Hua Jin, Guangdong Medical University, China

Assoc. Prof. Dr. Hua Jin is an Associate Professor at Guangdong Medical University, Dongguan, China, specializing in nanochemistry, bionanomaterials, and drug delivery systems. He holds a PhD from Jinan University, China, and completed postdoctoral fellowships at Northwestern University and the University of Illinois at Chicago. Dr. Jin has published over 50 SCI papers with an H-index of 34, and holds multiple international and Chinese patents. His research primarily focuses on nanoparticle-based therapies for lung injuries and cancer. Notable publications include works in J Tissue Eng and Biomaterials Science.

 

Publication profile

Orcid

Education

Assoc. Prof. Dr. Hua Jin earned his Ph.D. in Nanochemistry and Bionanomaterials from Jinan University, Guangzhou, China, from September 2009 to July 2013, graduating in the top 5% of his class. Prior to that, he completed his M.Eng. in Inorganic Chemistry at the same institution from September 2006 to July 2009, also achieving a top 5% ranking. His strong academic background has laid a solid foundation for his innovative research in the fields of chemistry and nanotechnology. 🌟🔬✨

 

Work Experience

Assoc. Prof. Dr. Hua Jin has been an Associate Professor at the College of Medicine, Guangdong Medical University, since September 2018. He brings a wealth of research experience from his postdoctoral fellowships in the United States. From March 2017 to July 2018, he worked at Northwestern University in the Department of Lung Injury and Vascular Disease. Prior to that, from November 2013 to March 2017, he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois at Chicago. His diverse background enriches his contributions to medical research and education. 🌟🔬

 

Research Achievements

Assoc. Prof. Dr. Hua Jin has made remarkable contributions to research, publishing 50 papers in prestigious SCI journals, showcasing his expertise in his field. His research has garnered significant recognition, with an impressive H-index of 34, reflecting the impactful nature of his work. Dr. Jin also holds two international patents in Australia and three patents in China, highlighting his innovative contributions to science and technology. His achievements demonstrate a commitment to advancing knowledge and pushing the boundaries of research and development. 🌍📚💡

 

Publication Top Notes  

  • Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury (2024) – [Cited by: 2] 🔬
  • Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation (2021) – [Cited by: 15] 📈
  • Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma via Enhancing IL-12 Expression (2021) – [Cited by: 10] 🌱
  • Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway (2021) – [Cited by: 8] 🥇
  • GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy (2021) – [Cited by: 5] 💊
  • Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury (2021) – [Cited by: 3] 🐭
  • Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances (2020) – [Cited by: 20] 📚
  • Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli (2020) – [Cited by: 12] 🦠
  • Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis (2020) – [Cited by: 18] 🎯
  • EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy (2017) – [Cited by: 6] 🌼